Rising costs in pharmaceutical expenditure have become a major concern for policy makers in Germany over the last years. Therefore the pharmaceutical market in Germany has been increasingly targeted by different kinds of regulations, focussing both on the supply and the demand side, using price,...

"This book is a business history of a transnational Japanese pharmaceutical company in the early twentieth century, Hoshi Pharmaceuticals, and a commodity history of its involvement in opium, quinine, and consumer medicines in both Japan and its expanding empire."